公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2009 | Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma | DA-LIANG OU ; Ying-Chun Shen ; JA-DER LIANG ; Liou J.-Y.; SUNG-LIANG YU ; Fan H.-H.; Wang D.-S.; YEN-SHEN LU ; CHIUN HSU ; ANN-LII CHENG | Clinical Cancer Research | 32 | 34 | |
2010 | Induction of DNA damage-inducible gene GADD45β contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells | DA-LIANG OU ; Ying-Chun Shen ; SUNG-LIANG YU ; Chen K.-F.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; LIANG-IN LIN ; CHIUN HSU ; ANN-LII CHENG | Cancer Research | 70 | 69 | |
2002 | Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin | CHIH-HUNG HSU ; Hergenhahn M.; Chuang S.-E.; Yeh P.-Y.; Wu T.-C.; Gao M.; ANN-LII CHENG | Anticancer Research | 15 | 13 | |
2011 | Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials | SHIH-HUNG YANG ; Kuo Y.-H.; YU-WEN TIEN ; CHIUN HSU ; CHIH-HUNG HSU ; SUNG-HSIN KUO ; ANN-LII CHENG | Oncology | 13 | 13 | |
1997 | Infrequent hMSH2 mutations in sporadic gastric adenocarcinoma with microsatellite instability | MING-SHIANG WU ; JIN-CHUAN SHEU; CHIA-TUNG SHUN ; Lee W.-J.; JIN-TOWN WANG ; Wang T.-H.; ANN-LII CHENG ; Lin J.-T. | Cancer Letters | 31 | 29 | |
2000 | Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats | Chuang S.-E.; ANN-LII CHENG ; Lin J.-K.; Kuo M.-L. | Food and Chemical Toxicology | 181 | 151 | |
2012 | Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells | Chen K.-F.; Lin J.-P.; Shiau C.-W.; Tai W.-T.; Liu C.-Y.; Yu H.-C.; PEI-JER CHEN ; ANN-LII CHENG | Biochemical Pharmacology | 50 | 50 | |
2013 | Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma | Yu H.-C.; Chen H.-J.; Chang Y.-L.; Liu C.-Y.; Shiau C.-W.; ANN-LII CHENG ; Chen K.-F. | Biochemical Pharmacology | 45 | 44 | |
1998 | Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen | ANN-LII CHENG ; Chuang S.-E.; Fine R.L.; KUN-HUEI YEH ; Liao C.-M.; Lay J.-D.; Chen D.-S. | Biochemical Pharmacology | 69 | 65 | |
2016 | Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma | Lin H.-H.; Feng W.-C.; LI-CHUN LU ; YU-YUN SHAO ; CHIH-HUNG HSU ; ANN-LII CHENG | Cancer letters | 36 | 39 | |
2014 | Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behavior | Huang W.-T.; SUNG-HSIN KUO ; ANN-LII CHENG ; CHUNG-WU LIN | Modern Pathology | 17 | 15 | |
2005 | Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro | CHIH-HUNG HSU ; Gao M.; Chen C.-L.; Yeh P.-Y.; ANN-LII CHENG | Oncology | 39 | 37 | |
2004 | Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells | YEONG-SHIAU PU ; Hour T.-C.; Chuang S.-E.; ANN-LII CHENG ; Lai M.-K.; Kuo M.-L. | Prostate | 70 | 71 | |
2003 | Involvement of nuclear transcription factor-κB in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells | Yeh P.Y.; Chuang S.-E.; KUN-HUEI YEH ; Song Y.C.; ANN-LII CHENG | Biochemical Pharmacology | 37 | 31 | |
2017 | Irinotecan and oxaliplatin might provide equal benefit as adjuvant chemotherapy for patients with resectable synchronous colon cancer and liver-confined metastases: A nationwide database study | YI-HSIN LIANG ; YU-YUN SHAO ; Chen, Ho Min; ANN-LII CHENG ; Lai, Mei Shu; KUN-HUEI YEH | Anticancer Research | 10 | 11 | |
2011 | IκB kinases increase Myc protein stability and enhance progression of breast cancer cells | Yeh P.-Y.; YEN-SHEN LU ; DA-LIANG OU ; ANN-LII CHENG | Molecular Cancer | 24 | 23 | |
2019 | Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinoma | ZHONG-ZHE LIN ; CHIUN HSU ; YUNG-MING JENG ; Hu F.-C.; Pan H.-W.; YAO-MING WU ; Hsu H.-C.; ANN-LII CHENG | Liver International | 18 | 18 | |
2012 | KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells | Lin Y.-L.; JAU-YU LIAU ; SHAN-CHI YU ; DA-LIANG OU ; LIANG-IN LIN ; LI-HUI TSENG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG | PLoS ONE | 43 | 35 | |
2011 | Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001 | SUNG-HSIN KUO ; CHIH-HUNG HSU ; Chen L.-T.; YEN-SHEN LU ; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; KUN-HUEI YEH ; ANN-LII CHENG | European Journal of Cancer | 17 | 17 | |
2004 | Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines | Ying-Chun Shen ; CHIUN HSU ; Chen J.-Y.; ANN-LII CHENG | British Journal of Cancer | 4 | 5 | |